LGND - Ligand Pharmaceuticals Inc. (LGND) CEO John Higgins on Q4 2019 Results - Earnings Call Transcript
Ligand Pharmaceuticals, Inc. (LGND)
Q4 2019 Results Conference Call
February 6, 2020 04:30 PM ET
CompanyParticipants
Patrick O'Brien - Supervisor of Investor Relations
John Higgins - Chief Executive Officer
Matt Korenberg - Executive Vice President, Finance and Chief Financial Officer
Matt Foehr - President and Chief Operating Officer
Conference Call Participants
Matt Hewitt - Craig-Hallum Capital Group
Joe Pantginis - H.C. Wainwright & Co
Larry Solow - CJS Securities
Balaji Prasad - Barclays
Presentation
Operator
It is now my pleasure to turn today's program over to Patrick O'Brien, Supervisor of Investor Relations. Sir, the floor